Reducing Smoking among People with Schizophrenia: Perspectives on Priorities for Advancing Research
- 1School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Australia
- 2Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, United Kingdom
- 3Flinders Human Behaviour and Health Research Unit, Flinders University, Australia
- 4Division of Addiction Psychiatry, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, United States
- 5Greater Manchester Mental Health NHS Foundation Trust, United Kingdom
- 6Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom
- 7St Vincent's Hospital (Melbourne), Australia
- 8Department of Psychiatry, Melbourne Medical School, University of Melbourne, Australia
Although tobacco smoking is very common among people with schizophrenia and has devastating effects on health, strategies to ameliorate the risk are lacking. Some studies have reported promising results yet quit rates are much lower than in the general population. There is a need to advance research into smoking cessation efforts among people with schizophrenia. We posed the following question to five leading international experts in the field: “What are the top three research ideas we need to prioritize in order to advance the field of reducing smoking amongst people with schizophrenia?” They identified three broad priorities: (i) deeper understanding about the relationship between smoking, smoking cessation and symptomatology; (ii) targeted, adaptive and responsive behavioural interventions evaluated with smarter methodologies; and (iii) improvements in delivery of interventions. Efforts should be made to establish a collaborative international research agenda.
Keywords: Smoking, Smoking Cessation, Schizophrenia, Research, Health Priorities, severe mental illness, Mentally Ill Persons, Vulnerable population
Received: 31 Aug 2018;
Accepted: 04 Dec 2018.
Edited by:Thomas W. Weickert, University of New South Wales, Australia
Reviewed by:Suresh Sundram, Monash University, Australia
Julia M. Lappin, University of New South Wales, Australia
Copyright: © 2018 Baker, Robson, Lawn, Steinberg, Bucci, McNeill, Castle and Bonevski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Prof. Amanda L. Baker, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Newcastle, 2308, Australia, Amanda.Baker@newcastle.edu.au
Dr. Sandra Bucci, Greater Manchester Mental Health NHS Foundation Trust, Manchester, M25 3BL, United Kingdom, Sandra.Bucci@manchester.ac.uk